Track the 경남제약 share price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares are quoted on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 경남제약 has recorded 57 insider filings. Market capitalisation: €27.4bn. The latest transaction was filed on 8 July 2026 (Other). Among the most active insiders: 빌리언스. The full history is accessible without an account.
56
Insider Decl.
n/a
Thresholds
n/a
15 ops.
Buy Volume
n/a
25 ops.
Sell Volume
Fundamental score
Ranked 27,139 of 29,057 companies
17.9
score / 100
Value
12
Quality
24
FCF yld-9.9%
Earn yld-30%
EV/EBITDA·
ROE·
Gross mgn27%
Net mgn-16%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.